1. Oesophagus Fact Sheet. Global Cancer Observatory (GLOBOCAN 2022), International Agency for Research on Cancer (IARC).
2. Wu SG, Zhang WW, He ZY, Sun JY, Chen YX, Guo L. Sites of metastasis and overall survival in esophageal cancer: a population-based study. Cancer Management and Research. 2017; 9: 781–788.
3. Madariaga ML, Gaissert HA. Secondary tracheal tumors: a systematic review. Annals of Cardiothoracic Surgery. 2018; 7(2):183.
4. Neeraj Gupta. Endobronchial metastasis: The challenge continues. Lung India. 2019; 36(3): 181-182.
5. Goense L, Van Rossum PS, Reitsma JB, Lam MG, Meijer GJ, Van Vulpen M, et al. Diagnostic performance of 18F-FDG PET and PET/CT for the detection of recurrent esophageal cancer after treatment with curative intent: a systematic review and meta-analysis. Journal of Nuclear Medicine. 2015; 56(7): 995-1002.
6. Gresham E, Parsa FD. Iatrogenic implantation of cancer cells during surgery. Hawai'i Journal of Health & Social Welfare. 2020; 79(1):4.
7. Kosugi SI, Kanda T, Nishimaki T, Nakagawa S, Yajima K, Ohashi M, et al. Successful treatment for esophageal carcinoma with lung metastasis by induction chemotherapy followed by salvage esophagectomy: Report of a case. World Journal of Gastroenterology. 2006; 12(25): 4101.
8. Liu D, Lu M, Li J, Yang Z, Feng Q, Zhou M, et al. The patterns and timing of recurrence after curative resection for gastric cancer in China. World Journal of Surgical Oncology. 2016; 14(1): 305.
9. Takashima S, Okubo S, Ota M. An Iatrogenic Metastasis. The American Journal of Medicine. 2015; 128(9): e15-6.
10.Ayaz S. The Situations Which May Cause False-Negative Results in Oncological FDG-PET/CT Practice. The Ulutas Medical Journal. 2017; 3(1): 23-4.
11.Connolly JL, Schnitt SJ, Wang HH, Longtine JA, Dvorak A, Dvorak HF. Role of the Surgical Pathologist in the Diagnosis and Management of the Cancer Patient. In: Kufe DW, Pollock RE, Weichselbaum RR, et al, editors. Holland-Frei Cancer Medicine. 6th edition. Hamilton (ON): BC Decker; 2003.